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Abstract We show here that murine erythroleukemia (MEL) 
cells, following induction with hexamethylene bisacetamide, 
accumulate high mobility group (HMG)t protein onto the 
external surface of the cell in a membrane-associated form 
detectable by immunostaining with a specific anti-HMGt protein 
antibody. This association is maximal at a time corresponding to 
cell commitment. At longer times, immunostainable cells are 
progressively reduced and become almost completely undetect-
able along with the appearance of hemoglobin molecules. Binding 
to MEL cells does not affect the native molecular structure of 
"MGt protein. The type of functional correlation between 
"MGt protein and MEL cell differentiation is suggested by the 
observation that if an anti-HMGt protein antibody is added at 
the same time of the inducer almost complete inhibition of cell 
differentiation is observed, whereas if the antibody is added 
within the time period in which cells undergo through irreversible 
commitment, inhibition progressively disappears. A correlation 
between MEL cell commitment and the biological effect of 
HMGt protein can thus be consistently suggested. 
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1. Introduction 
The molecular mechanisms underlying the chemical induc-
tion of MEL cell differentiation, stimulated by polar-apolar 
chemical compounds [1,2], have not so far been identified. 
During the cell commitment period [3], among a well-estab-
lished series of metabolic changes [4--7], it has been demon-
strated that MEL cells rapidly release into the extracellular 
medium significant amounts of HMGI protein [8]. The pres-
ence in the extracellular medium of the HMGI protein is of 
crucial importance for MEL cell differentiation as indicated 
by the following observations: (i) the external addition of this 
protein promotes acceleration in the rate of differentiation of 
slow HMBA responding clones [8]; (ii) extracellular HMGI 
protein accelerates the down-regulation of oPKC, a condition 
favouring MEL cell differentiation [9]; (iii) increasing or de-
creasing the rate of HMG 1 protein release, and thereby affect-
ing the concentration of the extracellular protein, results in an 
increase or decrease in the rate of MEL cell differentiation 
[10]. Reports from other laboratories have indicated that 
HMG I protein, although considered on the basis of its mo-
*Corresponding author. Fax: (39) (10) 354415. 
Abbreviations: HMG, high mobility group; MEL, murine erythroleu-
kemia; HMBA, hexamethylene bisacetamide; PKC, protein kinase C 
lecular structure a DNA-binding protein [11], can perform 
specific biological functions, related to neurite outgrowth, 
when present in the extracellular compartment [12]. However, 
no precise information is available at present on the mecha-
nism(s) of interaction of HMGl protein with the cell mem-
brane or on the type of signal transduced. Hori et al. [13] have 
recently reported that the receptor for advanced glycation end 
products (RAGE) is capable of binding HMG1 protein, 
although with an affinity of order higher than nanomolar, 
thus leaving open the problem concerning the existence of a 
specific HMG 1 protein receptor. In this study we demon-
strate, at first, that the release of HM G I protein by induced 
MEL cells is due to a cell export mechanism which does not 
involve the ER-Golgi system and then we show that extracel-
lular HMG 1 protein, through the interaction with the external 
cell surface, expresses a new function crucially related to com-
mitment of the cell to terminal erythroid differentiation. At 
present, several questions remain to be solved. It is in fact still 
unknown how this protein, lacking the signal peptide, can be 
exported from the cell, how the association with the cell mem-
brane occurs, and finally if the protein undergoes internaliza-
tion into the cell. 
2. Materials and methods 
2.1. Cell culture and differentiation 
MEL cell clones characterized by a slow (N23 clone) or rapid (C44 
clone) rate of differentiation were obtained and cultured as described 
[14]. The cells were free of mycoplasmal contamination as established 
by a routine assay performed on cell cultures using the Mycoplasma 
Detection Kit (Boehringer). If not otherwise indicated, cells were in-
duced at a cell density of 105/ml by addition of 5 mM hexamethylene 
bisacetamide (HMBA) (Sigma Chemical Co.) to I ml of culture me-
dium. At the indicated times, the percentage of differentiated cells was 
evaluated by staining with benzidine (Sigma Chemical Co.) [15]. 
2.2. Purification and assay of HMG} protein 
HMGI protein was obtained from the soluble fraction ofC44 MEL 
cells as described [16] and its activity was assayed as previously spec-
Hied [8]. One unit of HMGI protein is defined as the amount which 
doubles the proportion of benzidine reactive cells under the specified 
assay conditions. The specific activity of purified HMGI protein was 
2 units/ng. 
2.3. Evaluation of HMG} protein content in MEL cells and in the 
extracellular medium 
MEL cells (5 X 106 cells) were incubated at 37°C in 10 ml of com-
plete culture medium containing the additions reported in Section 3.1. 
After 4 h the cells and the culture medium were separately collected 
by centrifugation and the soluble cell fraction prepared as previously 
described [16]. Both the culture medium and the soluble cell fraction 
were submitted to affinity chromatography onto a I ml heparin-im-
mobilized column (EconoPac, Bio-Rad) previously equilibrated in 50 
mM sodium phosphate buffer, pH 7.0 [8]. The adsorbed proteins were 
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eluted with the same buffer containing 0.8 M NaC!. The peak of 
eluted proteins was collected and aliquots were used to assay 
HMGI protein activity as reported above. 
This step was introduced to concentrate large volumes of extracel-
lular medium and to reduce the total contaminant protein present in 
the complete culture medium. To normalize the experimental condi-
tions the same chromatographic procedure was carried out on the 
soluble cell fraction. 
2.4. Preparation of the anti-HMGl protein monoclonal antibody 
The anti-HMGI protein antibody (mAb 23.38) was produced and 
purified as described [10]. This antibody recognized HMGI protein as 
a single band with a molecular mass of 29 kDa in Western blot 
analysis and did not cross-react with other proteins of MEL cell 
lysate. 
2.5. Fluorescence microscopy 
MEL cells (3 X 106 cells) were fixed with 4% paraformaldehyde for 
30 min, washed three times with I ml of PBS buffer, pH 7.4 and 
suspended in 0.1 ml of the same buffer. Non-specific binding sites 
were blocked with 2% normal goat serum. The fixed cells were incu-
bated for 18 h at 4°C with 10 lJ.g/ml of purified anti-HMGI protein 
mAb 23.38. Cells were then washed as above and suspended in 50 IJ.I 
of PBS buffer, pH 7.4, containing 28 lJ.g/ml of fluorescein isothiocya-
nate-conjugated goat anti-mouse IgG (H+L) (Jackson Immuno Re-
search Laboratories). After I h at 20°C in the dark, cells were washed 
three times as above, suspended in 150 iJ.l of PBS buffer, pH 7.4 and 
analyzed with a Zeiss microscope (model IM35) equipped for epifluo-
rescence with appropriate filters to detect specifically the fluorescein 
isothiocyanate. A 40x objective (Zeiss) was used in all figures shown. 
As control, experiments in which the anti-HMGI protein mAb was 
omitted from the staining protocol were carried out in parallel; in this 
case no fluorescent cells were detectable. 
2.6. Labelling of HMGl protein with Na 1251 
Purified HMGI protein (10 IJ.g) was radiolabeled employing the 
chloramine T method [17] using 0.5 mCi of carrier-free Na125 I (Amer-
sham). 125I_HMGI protein was separated from unreacted 1251 by gel 
chromatography onto a Sephadex G-25 (PD 10) column previously 
equilibrated in PBS buffer, pH 7.4. The specific activity of the eluted 
protein was about 3.7 X 107 cpm/lJ.g and its specific activity on stimu-
lating MEL cell differentiation was 1.8 units/ng. The radioactivity 
associated with HMG I protein was 95% precipitable in 20% trichloro-
acetic acid and migrated as a single band of 29 kDa on SDS-PAGE 
carried out in the presence of 2-mercaptoethanol [18]. 
2.7. Evaluation of 125/_HMGl protein binding to MEL cells 
MEL cells were suspended at a concentration of 107 cells/ml in 
complete culture medium containing 170 pM 125I_HMGI protein 
and were induced by addition of 5 mM HMBA. At the times indi-
cated in Section 3.3, 3 ml of the cell suspension were collected, and 
layered on the top of a discontinuous gradient of Ficoll 400 (Pharma-
cia) containing 8 ml of 3% (w:v) Ficoll solution in the upper layer and 
I ml of 9% (w:v) Ficoll solution in the lower layer. After 20 min of 
centrifugation at 1000 X g the cell layer at the interphase between the 
Table I 
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9 and 3% Ficoll steps was collected and the cells diluted at I ml in 
PBS buffer, pH 7.4 containing 10 lJ.g/mlleupeptin, 10 lJ.g/ml aprotinin 
and I mM phenylmethylsulfonyl fluoride. The cells were then 
counted, lysed by sonication and the cytosolic and the membrane 
fractions were obtained as described [19]. Aliquots of cell soluble 
and membrane fractions, corresponding to 3 X 106 cells, were sub-
jected to SDS-PAGE on a 12% polyacrylamide slab gel in the pre-
sence of 2% 2-mercaptoethanol. 
3. Results 
3.1. Characterization of the HMG1 protein secretion process 
from MEL cell 
To define the possible mechanism of secretion of HMG I 
protein, we have treated MEL cells with compounds known to 
affect at different levels the protein release. As shown in Table 
I, untreated MEL cells release small amounts of HMGI pro-
tein corresponding to approx. 2% of the total. This amount of 
extracellular HMG I protein activity is likely due to lysis of 
dead cells during the incubation time and corresponds to the 
percentage of release of soluble marker enzymes, such as al-
dolase. Treatment with HMBA produces considerable release 
of HMG I protein corresponding to approx. 60 and 25% of 
the total, for C44 and N23 cells respectively. No increase in 
the level of the cytosolic marker enzyme in the culture me-
dium is observed, indicating that the release of HMG I protein 
is not due to aspecific cell damage. Addition of methylamine 
to HMBA stimulated MEL cells promotes 35% inhibition of 
HMG I protein export. Similar results (43% inhibition) are 
obtained by lowering the temperature of incubation of 
HMBA stimulated MEL cells to 16°C. Monensin, known to 
affect the protein traffic between the ER and Golgi complex 
[20], is ineffective on HMG I protein secretion by induced 
MEL cells. However, treatment of MEL cells with the calcium 
ionophore A23187, added to the culture medium in the 
absence of HMBA, promotes the release of HMG I protein 
in an amount comparable to that recovered after cell treat-
ment with HMBA alone. Exposure of MEL cells to the tumor 
promoter phorbol12-myristate 13-acetate results in release of 
HMGI protein slightly higher than that induced by HMBA 
alone. 
Taken together, these results indicate that the secretion of 
HMG 1 protein is a process in which the ER or Golgi complex 
do not seem to be involved, and is stimulated by intracellular 
increase in Ca2+ concentration and possibly by the activation 
of a Ca2+ -dependent PKC isoforrn. 
Effect of drugs or treatments on the release of HMG I protein from MEL cells 
Treatment C44 clone 
-----------------------------
None 
HMBA,5mM 
HMBA, 5 mM +methylamine, 5 mM 
HMBA, 5 mM+low temperature (16°C) 
HMBA, 5 mM +monensin, 10 IJ.M 
A23187, I IJ.M 
Phorbol myristate acetate, 100 ng/ml 
HMG I protein 
(% of total) 
2 
61 
40 
35 
59 
54 
75 
Aldolase 
(% of total) 
1.6 
2.8 
2.1 
1.8 
2.5 
2.5 
3.0 
N23 clone 
HMGI protein 
(% of total) 
2 
25 
15 
13 
26 
21 
37 
Aldolase 
(% of total) 
2.0 
4.5 
2.8 
2.8 
3.2 
4.0 
5.6 
MEL cells (5 X 106 cells) were incubated in 10 ml of complete culture medium containing the indicated additions. Following incubation for 4 h at 
37°C, the culture medium and the soluble cell fractions were obtained as specified under Section 2. To assay HMGI protein activity, the two 
solutions were chromatographed onto a heparin-immobilized column and the peak of proteins eluted with 0.8 M NaC! was used. The aldolase 
activity was assayed on the culture medium and soluble cell fraction as described by Gracy et al. [28]. As 100% was considered the amount of 
activity of both HMGI protein or aldolase present in the soluble fraction of the same quantity of untreated cells. 
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Fig. I. Immunoreactivity of intact MEL cells with the anti-HMGl protein mAb 23.38. Uninduced N23 (A) and C44 (D) cells or HMBA in-
duced cells were fixed and treated with anti-HMGI protein mAb 23.38 as primary antibody and fluorescein isothiocyanate-conjugated goat 
anti-mouse Ig as secondary antibody as reported under Section 2. The cells were then analyzed with a Zeiss microscope as specified in Section 
2. Band C refer to the N23 clone, after 4 and 16 h of exposure to HMBA, respectively. E and F refer to the C44 clone, after 2 and 4 h of ex-
posure to HMBA, respectively. 
3.2. Binding of HMGI protein to intact cells 
To reveal if HMGI protein, once released, is taken up by 
MEL cells, we evaluated the presence of the protein factor on 
the external surface of cells using immunostaining with an 
anti-HMGI protein monoclonal antibody. As shown in Fig. 
I, both N23 (A) and C44 (D) MEL cells are almost complete-
ly unstainable in the absence of HMBA. Following exposure 
to the inducer, cells become progressively immunofluorescent, 
indicating the presence of HMG I protein on their surface 
(Fig. IB, N23 cells after 4 h; C, N23 cells after 14 h; E, 
C44 cells after 2 h; F, C44 cells after 4 h). The kinetics of 
immunostaining are reported in Fig. 2. With C44 clone, cells 
become immunofluorescent very rapidly, and after 3-4 h of 
exposure to HMBA, approx. 70% of the cells are recognized 
by the anti-HMG I protein antibody. After this time the num-
ber of immunopositive cells decreases and, at 16 h of incuba-
tion, all cells are insensitive to the antibody. MEL cell clone 
N23 shows different kinetics, reaching a maximum (45%) of 
immunostainable cells at 14-16 h of incubation; thereafter a 
decline in the number of positive cells is observed and at 48 h 
only few cells are immunofluorescent. It is important to note 
that the induced cells of both MEL cell clones become insen-
sitive to HMG 1 protein once they have reached the fully 
irreversible committed state and initiate to synthesize hemo-
globin [14,21]. 
3.3. Binding of 1251-labelled HMGI protein to MEL cell 
membranes 
The binding of HMG 1 protein to the external surface of 
induced MEL cells was further confirmed by experiments in 
which radiolabelled HMG 1 protein was added to the culture 
medium of C44 MEL cells together with the chemical inducer 
HMBA and, after removal of unbound 125I_HMGl protein, 
the membrane and soluble cell fraction were separately ana-
lyzed for the presence of 125I_HMGl protein. As shown in 
Fig. 3, the radiolabelled protein was found almost exclusively 
bound to the membrane fraction of HMBA induced cells and 
only 1-2% of the total radioactivity was recovered in the 
soluble cell fraction. The kinetics of binding, including the 
time required to reach maximal association (4 h), were found 
to be almost identical to that observed (see Fig. 2) in experi-
ments in which the binding of HMG 1 protein was evaluated 
on the C44 clone by immunostaining of intact cells with the 
anti-HMGI protein mAb 23.38. At all times, the radioactive 
material analyzed by SDS-PAGE (see top of Fig. 3) was re-
covered as a single band with a molecular mass of 29 kDa, 
identical to that of the native HMGl protein. 
These results support the concept that binding of HMG 1 
protein occurs only in HMBA induced cells, and is not ac-
companied by modification of the molecular structure of the 
protein. Thus, the native HMG 1 protein, once associated with 
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Fig. 2. Kinetics of binding of HMGI protein to the external surface 
of MEL cell clones. Binding of HMGI protein to C44 (e) and N23 
(0) MEL cells was detected by immunostaining with the anti-
HMGI protein mAb 23.38, as described in the legend to Fig. I and 
in Section 2. At the indicated times, the percentage of immunofluo-
rescent cells was evaluated by counting a total of 103 cells. 
MEL cell membranes, can express without further modifica-
tion its stimulatory activity on MEL cell differentiation. 
3.4. Timing of HMGl protein action 
In order to identify the time at which HMG 1 protein exerts 
its extracellular function, C44 cells were induced with HMBA 
and the anti-HMGl protein mAb 23.38 was subsequently 
added at different time intervals. As shown in Fig. 4, when 
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Fig. 3. Distribution of 125I_HMGI protein bound to C44 MEL cell 
during the commitment. 125I-HMGl protein was obtained and incu-
bated with C44 MEL cells in the presence or absence of 5 mM 
HMBA as reported in Section 2. At the indicated times, aliquots of 
the cell suspension, containing 3 x 107 cells, were collected and 
loaded on a Ficoll gradient, to remove unbound labelled HMGI 
protein. One tenth of the cells were then utilized for the preparation 
of the soluble and membrane fractions (see Section 2). The subcellu-
lar fractions were analyzed on SDS-PAGE. The dried slab gels were 
exposed to X-ray film for autoradiography, the radioactive protein 
bands were excised from the gel and the associated radioactivity de-
termined using a y-counter. The inset shows the autoradiogram ob-
tained with the membrane cell fraction, following induction for the 
indicated times. 
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the antibody was added at the same time as the inducer, al-
most complete inhibition of the MEL cell differentiation proc-
ess was observed. When the antibody was added at a time 
corresponding to the maximal accumulation of HMG 1 pro-
tein on the external surface (4 h) or at longer times, when full 
cell commitment is already reached (approx. 8 h), the inhibi-
tory efficiency of the antibody was profoundly reduced or 
completely abolished, respectively. This result indicates that 
the effect of HMG 1 protein is confined to the early phase of 
MEL cell differentiation and correlated to the onset of cell 
commitment. 
4. Discussion 
In recent years, several data have been obtained demon-
strating that HMG 1 protein is an intracellular protein ex-
pressed by MEL cells and released into the culture medium 
following cell stimulation with the inducer HMBA [8]. The 
data presented in this paper are intended to provide a plaus-
ible understanding of the mechanism involved in this release 
since HMGI protein lacks the typical hydrophobic secretory 
signal [22]. It has been preliminarily established that the ex-
port of this protein cannot be ascribed to aspecific leakage. 
Moreover, it has been observed that HMBA induced export 
of HMG 1 protein is inhibited by methylamine or by lowering 
the temperature of incubation [23,24], but is unaffected by the 
addition of monensin [20]. Thus, it can be postulated that in 
MEL cells the mechanism for the release of this protein does 
not involve the ER-Golgi system. 
Extracellular release of HMG 1 protein in significant 
amounts by intact uninduced MEL cells has been reproduced 
by cell treatment with A23187 Ca2+ ionophore or with a 
phorbol ester. In the first case, an increase in the intracellular 
concentration of Ca2+ occurs, in the second one the implica-
tion of PKC activity can be postulated [25]. Both observations 
deserve additional experiments but it might be relevant to 
recall that variation in Ca2+ influx and activation of PKC 
have been demonstrated to be involved in the early steps of 
MEL cell differentiation [19,26,27]. Direct experimental evi-
OL---~----L---~--~~ 
o 2 4 6 8 
TIME, hours 
Fig. 4. Changes in the sensitivity of MEL cells to the inhibitory ef-
fect of anti-HMGl protein mAb 23.38 during HMBA induced dif-
ferentiation. C44 MEL cells were induced as reported under Section 
2. At the indicated times, also the purified anti-HMGl protein mAb 
23.38 (40 J.lg/ml) was added to the cell culture. The number of dif-
ferentiated cells was determined following 36 h of exposure to 
HMBA. The data are expressed as percentage of inhibition exerted 
by the antibody. 
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dence has been obtained indicating that following induction 
with HMBA, MEL cells secrete and accumulate HMG I pro-
tein on the external cell surface in a membrane-associated 
form. The kinetics of this phenomenon are correlated with 
the rate of MEL cell differentiation being faster in the rapidly 
responding clone as compared to the slowly responding one. 
However, in both cases, maximum association occurs at a 
time that roughly corresponds to the onset of irreversible 
cell commitment [14]. 
The use of radiolabelled HMG I protein added to the cul-
ture medium together with the inducer has provided the fol-
lowing important information: (I) HMGI protein associates 
almost exclusively at the external cell surface; (2) the kinetics 
of this binding confirm that maximum association coincides 
with cell commitment; (3) within the time considered, and 
until the HMGI protein effect is completed, its association 
with the cell membrane occurs without extensive modification 
of the native molecular structure. 
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